ropinirole and Movement Disorders
ropinirole has been researched along with Movement Disorders in 7 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Ropinirole is a non-ergoline selective D2 dopamine agonist." | 1.34 | [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy]. ( Angersbach, D; Buchwald, B; Jost, WH, 2007) |
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors
Authors | Studies |
---|---|
Wang, Y | 1 |
Bouabid, S | 1 |
Darvas, M | 1 |
Zhou, FM | 1 |
Kim, HJ | 1 |
Park, SY | 1 |
Cho, YJ | 1 |
Hong, KS | 1 |
Cho, JY | 1 |
Seo, SY | 1 |
Lee, DH | 1 |
Jeon, BS | 1 |
Hersh, BP | 1 |
Earl, NL | 1 |
Hauser, RA | 1 |
Stacy, M | 1 |
Salamone, JD | 1 |
Carlson, BB | 1 |
Rios, C | 1 |
Lentini, E | 1 |
Correa, M | 1 |
Wisniecki, A | 1 |
Betz, A | 1 |
Buchwald, B | 1 |
Angersbach, D | 1 |
Jost, WH | 1 |
Stockwell, KA | 1 |
Virley, DJ | 1 |
Perren, M | 1 |
Iravani, MM | 1 |
Jackson, MJ | 1 |
Rose, S | 1 |
Jenner, P | 1 |
Rascol, O | 1 |
Lees, AJ | 1 |
Senard, JM | 1 |
Pirtosek, Z | 1 |
Brefel, C | 1 |
Montastruc, JL | 1 |
Fuell, D | 1 |
Trials
2 trials available for ropinirole and Movement Disorders
Article | Year |
---|---|
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.
Topics: Aged; Delayed-Action Preparations; Dopamine Agonists; Double-Blind Method; Female; Humans; Indoles; | 2010 |
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Movem | 1996 |
Other Studies
5 other studies available for ropinirole and Movement Disorders
Article | Year |
---|---|
The antiparkinson drug ropinirole inhibits movement in a Parkinson's disease mouse model with residual dopamine neurons.
Topics: Animals; Antiparkinson Agents; Dopaminergic Neurons; Homeodomain Proteins; Indoles; Male; Mice; Mice | 2020 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; | 2009 |
Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
Topics: Analysis of Variance; Animals; Cholinergic Agents; Disease Models, Animal; Dopamine Agonists; Dose-R | 2005 |
[Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Disabi | 2007 |
Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Drug Administrati | 2008 |